Catalyst
Slingshot members are tracking this event:
Array Bio (ARRY) and Pierre Fabre Announces PHASE 3 COLUMBUS Results Evaluating LGX818 + MEK162 in Melanoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARRY |
|
|
Pierre Fabre |
|
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 26, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Encorafenib, Binimetinib, Lgx818, Mek162, Unresectable Or Metastatic Melanoma, Phase 3 Columbus
